RHONDA ROBERTSON: Open Payments
NPI 1568464733 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 33 payments from 9 companies in 2025. Trend: 2023 $237 · 2024 $438 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $235 |
| ABBVIE INC. | 7 | $222 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Braeburn Inc. | 2 | $48 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 2 | $35 |
| Alkermes, Inc. | 1 | $16 |
| Indivior Inc. | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: CAPLYTA, VRAYLAR, Auvelity, BRIXADI, INVEGA SUSTENNA, FANAPT, VIVITROL, SUBLOCADE.
Industry payments across LA — which companies pay providers there.
